Archives for February 25, 2010

← 2010

Sandoz opens Slovenian biosimilars production plant

By Staff reporter

Lek has opened a 430m² modified protein manufacturing facility in Slovenia to produce epoetin alfa drug substance for use in the biosimilars marketed by its parent company, Sandoz.